LATEST NEWS
Bristol-Myers Squib and Pfizer Announce, Controlled Trial to Evaluate the Effect of Atrial Fibrillation Screening on Health Outcomes in Older Individuals
The Bristol-Myers Squibb-Pfizer Alliance today announced the initiation of a new randomized, controlled study, GUARD-AF (ReducinG stroke by screening for UndiAgnosed atRial fibrillation in...
Read More
Bristol-Myers Squibb Completes Acquisition of Celgene, Creating a Leading Biopharma Company
Bristol-Myers Squibb Company (NYSE:BMY) has announced that it has completed its acquisition of Celgene Corporation (NASDAQ:CELG) following the receipt of regulatory approval from all...
Read More
Massive Bio and The American Sexual Health Association Partner to Increase Patient Access to Cervical Cancer Clinical Trials
Massive Bio, a leader in Artificial Intelligence (AI) based oncology clinical trial enrollment, and The American Sexual Health Association (ASHA), a leader in advancing...
Read More
Quality Cancer Care Alliance Network (QCCA) Selects Integra Connect as Preferred Population Health Analytics Partner
Integra Connect, the leading provider of technologies and services for value-based specialty care, today announced it has been selected by the Quality Cancer Care...
Read More
Thermo Fisher Scientific Introduces First Next-Generation Sequencing Platform That Delivers Specimen to Report in a Single Day
Thermo Fisher Scientific announced the launch of its Ion Torrent Genexus System, the first fully integrated, next-generation sequencing (NGS) platform featuring an automated specimen-to-report...
Read More
Thermo Fisher Scientific Signs Agreement with Lilly Oncology for Companion Diagnostic to be Used with RET Inhibitor
Thermo Fisher Scientific today announced an agreement with Eli Lilly and Company for development of a companion diagnostic that will use the U.S Food...
Read More
